Refinement of the mouse model of congenital toxoplasmosis

Experimental Parasitology

Volumn 113, Issue 3, 2006, Pages 154-160

  Freyre, A ^a,b   Falcon J ^a   Mendez J ^b   Rodriguez, A ^a   Correa, L ^a   Gonzalez M ^b  

^a Department for Parasitology   (Uruguay)

^b Laboratory for Parasitology   (Uruguay)

Author keywords

Congenital toxoplasmosis; Mouse model

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DISEASE COURSE; DISEASE TRANSMISSION; EVOLUTIONARY HOMOLOGY; FEMALE; HETEROLOGOUS EXPRESSION; IMMUNE RESPONSE; INOCULATION; MALE; METHODOLOGY; MOUSE STRAIN; NEWBORN; NONHUMAN; OOCYST; PREGNANCY; PRIORITY JOURNAL; PROTECTION; SENSITIVITY AND SPECIFICITY; TOXOPLASMOSIS;

ANIMALS; CATS; DISEASE MODELS, ANIMAL; DISEASE TRANSMISSION, VERTICAL; FEMALE; IMMUNIZATION; MALE; MICE; MICE, INBRED BALB C; PREGNANCY TESTS; TIME FACTORS; TOXOPLASMOSIS, CONGENITAL; WEIGHT GAIN;

OVIS;

EID: 33744551120     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2005.12.019     Document Type: Article

References (27)

1. Abou-Bacar A., Pffaf A.W., Georges S., Letscher-Bru V., Filisetti D., Villard O., Antoni E., Klein J.P., and Candolfi E. Role of NK cells and γ interferon in transplacental passage of Toxoplasma gondii in a mouse model of primary infection. Infection and Immunity 72 (2004) 1397-1401
2. Allen E. The oestrus cycle in the mouse. American Journal of Anatomy 30 (1922) 297-348
3. Desmonts G., and Remington J.J. Direct agglutination test for diagnosis of Toxoplasma infection. Methods for increasing sensitivity and specificity. Journal of Clinical Microbiology 11 (1980) 562-568
4. In: Dubey J.P., and Beattie C.P. (Eds). Toxoplasmosis of Animals and Man (1988), CRC Press, Florida, US
5. Dubey J.P., and Shen K. Rat model of congenital toxoplasmosis. Infection and Immunity 59 (1991) 3301-3302
6. Elsaid M., Martins M., Frézard F., Braga E.M., and Vitor R.W.A. Vertical toxoplasmosis in a murine model. Protection after immunization with antigens of Toxoplasma gondii incorporated into liposomes. Memorias do Instituto Oswaldo Cruz 96 (2001) 99-104
7. Foster H.L., Small J., and Fox J.G. The Mouse in Biomedical Research vol. III (1983), Academic Press, London p. 151
8. Freyre A. Separation of Toxoplasma cysts from brain tissue and liberation of viable bradyzoites. Journal of Parasitology 81 (1995) 1008-1010
9. Freyre A., Falcón J., Correa O., Mendez J., González M., and Venzal J. Some factors influencing transmission of Toxoplasma in pregnant rats fed cysts. Parasitology Research 87 (2001) 915-918
10. Freyre A., Falcón J., Correa O., Mendez J., González M., and Venzal J. Fetal Toxoplasma infection after oocysts inoculation of pregnants rats. Parasitology Research 89 (2003) 352-353
11. Fux B., Ferreira A.M., Cassali G.D., Tafuri W.L., and Vitor R.W.A. Experimental toxoplasmosis in BALB/c mice. Prevention of vertical disease transmission by treatment and reproductive failure in chronic infection. Memorias do Instituto Oswaldo Cruz 95 (2000) 121-126
12. Gendron R.L., Nestel F.P., Lapp W.S., and Baines M.G. Lipopolysaccharide induced fetal resorption in mice is associated with the intrauterine production of tumor necrosis factor-α. Reproduction and Fertility 90 (1990) 395-402
13. Grimwood B., O'Connor G., and Gasfar H.A. Toxofactor associated with Toxoplasma gondii infection is toxic and teratogenic to mice. Infection and Immunity 42 (1983) 1126-1135
14. Gupta R.K., and Siber G.R. Adjuvants for human vaccines-current status, problems and future prospects. Vaccine 13 (1995) 1263-1276
15. Howe D.K., and Sibley D. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. Journal of Infectious Diseases 172 (1995) 1561-1566
16. Johnson J.L. A protective role for endogenous tumor necrosis factor in Toxoplasma gondii infection. Infection and Immunity 60 (1992) 1979-1983
17. Letscher-Bru V., Pffaf A.W., Abou-Bacar A., Filisetti D., Antoni E., Villard O., Klein J.P., and Candolfi E. Vaccination with Toxoplasma gondii SAG-1 protein is protective against congenital toxoplasmosis in BALB/c mice. Infection and Immunity 71 (2003) 6615-6619
18. Mc Leod R., Frenkel J., Estes R., Mack D.G., Eisenhower P.B., and Gibori G. Subcutaneous and intestinal vaccination with tachyzoites of Toxoplasma gondii and acquisition of immunity to peroral and congenital Toxoplasma challenge. Journal of Immunology 140 (1988) 1632-1637
19. Motomoura I., and Jo K. Estimation of the number of parasites contained within a Cyst, and growth and distribution of cysts in the brains of mice infected with Toxoplasma gondii. Tropical Medicine (Nagasaki) 12 (1970) 41-50
20. Nielsen H.V., Innes E.A., Petersen E., and Buxton D. Strategies for development of vaccines against Toxoplasma gondii. In: Thomas P.A., and Petersen E. (Eds). Congenital Toxoplasmosis (2000), Springer, Berlin, Heidelberg, New York 314-322
21. Remington J.S., and Desmonts G. Toxoplasmosis. In: Remington J.S., and Klein J.O. (Eds). Infectious Diseases of the Fetus and Newborn Infant (1990), Saunders, Philadelphia 90-195
22. Roberts C.W., and Alexander J. Studies on a murine model of congenital toxoplasmosis: vertical disease transmission only occurs in BALB/c mice infected for the first time during pregnancy. Parasitology 104 (1992) 19-23
23. Roberts C.W., Brewer J.M., and Alexander J. Congenital toxoplasmosis in the BALB/c mouse: prevention of vertical disease transmission and fetal death by vaccination. Vaccine 12 (1994) 1389-1394
24. Tarabla H. Epidemiología Diagnóstica (2000), Universidad Nacional del Litoral, Santa Fé (Argentina) pp. 37-53
25. Thouvenin M., Candolfi E., Villard O., Klein J.P., and Kient T. Immune response in a murine model of congenital toxoplasmosis: increased susceptibility of pregnant mice and transplacental passage of Toxoplasma gondii are Type-2 dependent. Parasitologia 39 (1997) 279-283
26. Zenner L., Darcy F., Cesbron-Delaw M., and Capron A. Rat model of congenital toxoplasmosis: rate of transmission of three Toxoplasma strains to fetuses and protective effects of a chronic infection. Infection and Immunity 61 (1993) 360-363
27. Zenner L., Estaquier J., Darcy F., Maes P., Capron A., and Cesbron-Delaw M. Protective immunity on the rat model of congenital toxoplasmosis and the potential of excreted-secreted antigens as vaccine components. Parasite Immunology 21 (1999) 261-272